Nina Hanke

1.3k total citations
40 papers, 1.1k citations indexed

About

Nina Hanke is a scholar working on Pharmacology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nina Hanke has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 14 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nina Hanke's work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (8 papers) and Hormonal Regulation and Hypertension (6 papers). Nina Hanke is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (8 papers) and Hormonal Regulation and Hypertension (6 papers). Nina Hanke collaborates with scholars based in Germany, United States and United Kingdom. Nina Hanke's co-authors include Thorsten Lehr, Rolf W. Hartmann, Renate Scheibe, Sebastian Frechen, Hans‐Peter Kubis, Thomas Wendl, Gerolf Gros, Hannah Britz, Thomas Eißing and Paul J. Schechter and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Medicinal Chemistry.

In The Last Decade

Nina Hanke

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nina Hanke Germany	20	308	299	193	158	126	40	1.1k
Rhys Whomsley Belgium	17	210 0.7×	211 0.7×	153 0.8×	244 1.5×	145 1.2×	36	928
Kazutomi Kusano Japan	20	269 0.9×	310 1.0×	241 1.2×	127 0.8×	72 0.6×	46	902
Ernesto Callegari United States	15	396 1.3×	421 1.4×	342 1.8×	158 1.0×	62 0.5×	29	1.3k
Dongsheng Ouyang China	24	492 1.6×	459 1.5×	186 1.0×	110 0.7×	55 0.4×	59	1.3k
Ajay Madan United States	20	561 1.8×	364 1.2×	366 1.9×	80 0.5×	50 0.4×	62	1.6k
Mitchell D. Green United States	17	582 1.9×	501 1.7×	322 1.7×	220 1.4×	42 0.3×	25	1.2k
Julie Ducharme Canada	20	341 1.1×	323 1.1×	272 1.4×	153 1.0×	75 0.6×	45	1.3k
Myung Gull Lee South Korea	21	639 2.1×	461 1.5×	421 2.2×	199 1.3×	48 0.4×	80	1.6k
Xiaoping Chen China	21	574 1.9×	335 1.1×	245 1.3×	140 0.9×	98 0.8×	45	1.3k

Countries citing papers authored by Nina Hanke

Since Specialization

Citations

This map shows the geographic impact of Nina Hanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Hanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Hanke more than expected).

Fields of papers citing papers by Nina Hanke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Hanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Hanke. The network helps show where Nina Hanke may publish in the future.

Co-authorship network of co-authors of Nina Hanke

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Hanke. A scholar is included among the top collaborators of Nina Hanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Hanke. Nina Hanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scherer, Nina, Dominik Selzer, Christiane Dings, et al.. (2023). Significant impact of time-of-day variation on metformin pharmacokinetics. Diabetologia. 66(6). 1024–1034. 22 indexed citations

Hanke, Nina, et al.. (2021). Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach. Pharmaceutics. 13(2). 270–270. 47 indexed citations

Hanke, Nina, et al.. (2021). Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network. Pharmaceutics. 13(3). 331–331. 14 indexed citations

Hanke, Nina, et al.. (2020). Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis. Clinical Pharmacokinetics. 59(6). 809–825. 11 indexed citations

Wojtyniak, Jan‐Georg, Dominik Selzer, Nina Hanke, et al.. (2020). Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions. Pharmaceutics. 12(12). 1200–1200. 17 indexed citations

Hanke, Nina, et al.. (2020). A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug–Drug Interaction Studies. Pharmaceutics. 12(6). 556–556. 16 indexed citations

Hanke, Nina, et al.. (2019). Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients. Pharmaceutics. 11(4). 152–152. 16 indexed citations

Hanke, Nina, Sebastian Frechen, Thomas Eißing, et al.. (2019). Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug–Drug–Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole. Clinical Pharmacokinetics. 58(12). 1595–1607. 41 indexed citations

Hanke, Nina, et al.. (2018). ATIM-13. ASUNERCEPT PLUS RADIOTHERAPY IN RELAPSED GLIOBLASTOMA. UPDATE ON FIVE YEARS OVERALL SURVIVAL OF STUDY NCT01071837 AND DEVELOPMENT OF A POPULATION-PK - TUMOR GROWTH INHIBITION - SURVIVAL MODEL. Neuro-Oncology. 20(suppl_6). vi3–vi3.

10.

Hanke, Nina, Michael Teifel, Jan‐Georg Wojtyniak, et al.. (2017). A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis. Cancer Chemotherapy and Pharmacology. 81(2). 291–304. 19 indexed citations

11.

Hanke, Nina, Hannah Britz, Sebastian Frechen, et al.. (2016). Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug–Drug Interactions and Co-medication Regimens. The AAPS Journal. 19(1). 298–312. 33 indexed citations

12.

Kubis, Hans‐Peter, Renate Scheibe, Karsten Hufendiek, et al.. (2015). Primary skeletal muscle cells cultured on gelatin bead microcarriers develop structural and biochemical features characteristic of adult skeletal muscle. Cell Biology International. 40(4). 364–374. 10 indexed citations

13.

Adam, Oliver, Christina Zimmer, Nina Hanke, et al.. (2015). Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice. Journal of Molecular and Cellular Cardiology. 85. 140–150. 32 indexed citations

14.

Perspicace, Enrico, et al.. (2014). Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors. European Journal of Medicinal Chemistry. 87. 203–219. 17 indexed citations

15.

Perspicace, Enrico, et al.. (2014). Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities. European Journal of Medicinal Chemistry. 83. 317–337. 17 indexed citations

16.

Dahal, Bhola K., Djuro Kosanovic, Josef Messinger, et al.. (2011). Role of mast cells and chymase in pulmonary vascular remodeling. European Respiratory Journal. 38(Suppl 55). p1524–p1524. 1 indexed citations

17.

Hanke, Nina, Renate Scheibe, Georgi Manukjan, et al.. (2011). Gene regulation mediating fiber-type transformation in skeletal muscle cells is partly glucose- and ChREBP-dependent. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(3). 377–389. 15 indexed citations

18.

Hanke, Nina, J. Meißner, Renate Scheibe, et al.. (2008). Metabolic transformation of rabbit skeletal muscle cells in primary culture in response to low glucose. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(5). 813–825. 13 indexed citations

19.

Kubis, Hans‐Peter, Nina Hanke, Renate Scheibe, & Gerolf Gros. (2005). Accumulation and nuclear import of HIF1 alpha during high and low oxygen concentration in skeletal muscle cells in primary culture. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1745(2). 187–195. 43 indexed citations

20.

Schechter, Paul J., Nina Hanke, Jeffrey Grove, Norman Huebert, & Albert Sjoerdsma. (1984). Biochemical and clinical effects of γ‐vinyl GABA in patients with epilepsy. Neurology. 34(2). 182–182. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact